journal article·2022-06Open access

Granular PEG hydrogels mediate osteoporotic MSC clustering via N-cadherin influencing the pro-resorptive bias of their secretory profile

Varsha V. Rao, Marissa E. Wechsler, Emily Cravens, Samantha J. Wojda, Alexander S. Caldwell, Bruce E. Kirkpatrick, Seth W. Donahue, Kristi S. Anseth

Acta Biomaterialia· Volume 145

Abstract

Postmenopausal osteoporosis results from a pro-resorptive bone environment, which decreases bone mineral density causing increased fracture risk. Bone marrow derived mesenchymal stem/stromal cells (MSCs) secrete factors involved in bone homeostasis, but osteoporosis mediated changes to their secretions remain understudied. Herein, we examined the secretome of MSCs isolated from ovariectomized rats (OVX rMSCs), a model of post-menopausal osteoporosis, as a function of cell-cell interactions. Specifically, we controlled clustering of OVX and SHAM rMSCs by assembling them in granular hydrogels synthesized from poly(ethylene glycol) microgels with average diameters of ∼10, 100, and 200 µm. We directed both the sizes of rMSC clusters (single cells to ∼30 cells/cluster) and the percentages of cells within clusters (∼20-90%) by controlling the scaffold pore dimensions. Large clusters of OVX rMSCs had a pro-resorptive secretory profile, with increased concentrations of Activin A, CXCL1, CX3CL1, MCP-1, TIMP-1, and TNF-ɑ, compared to SHAM rMSCs. As this pro-resorptive bias was only observed in large cell clusters, we characterized the expression of several cadherins, mediators of cell-cell contacts. N-cadherin expression was elevated (∼4-fold) in OVX relative to SHAM rMSCs, in both cell clusters and single cells. Finally, TIMP-1 and MCP-1 secretion was only decreased in large cell clusters of OVX rMSCs when N-cadherin interactions were blocked, highlighting the dependence of OVX rMSC secretion of pro-resorptive cytokines on N-cadherin mediated cell-cell contacts. Further elucidation of the N-cadherin mediated osteoporotic MSC secretome may have implications for developing therapies for postmenopausal osteoporosis. STATEMENT OF SIGNIFICANCE: Postmenopausal osteoporosis is a prevalent bone disorder that affects tens of millions of women worldwide. This disease is characterized by severe bone loss resulting from a pro-resorptive bone marrow environment, where the rates of bone resorption outpace the rates of bone deposition. The paracrine factors secreted by bone marrow MSCs can influence cell types responsible for bone homeostasis, but the osteoporosis-mediated changes to MSC secretory properties remains understudied. In this study, we used PEG-based porous granular scaffolds to study the influence of cell clustering on the secretory properties of osteoporotic MSCs. We observed increased secretion of several pro-resorptive factors by osteoporotic MSCs in large clusters. Further, we explored the dependence of this altered secretion profile on N-cadherin mediated cell-cell contacts.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mesenchymal stem cell research · Bone Metabolism and Diseases · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Osteoporosis: the Result of an ‘Aged’ Bone Microenvironment10.1016/j.molmed.2016.06.002 ↗
2. Postmenopausal osteoporosis10.1038/nrdp.2016.69 ↗
3. D. Wu, A. Cline, E. Shashkova, R. Aurora, Osteoporosis: A Multifactorial Disease, in: Osteoporosis - Recent Advances, New Perspectives and Applications, 2021. https://doi.org/10.5772/intechopen.97549.10.5772/intechopen.97549 ↗
4. How to grow bone to treat osteoporosis and mend fractures10.1007/s11914-003-0006-7 ↗
5. Fracture healing in osteoporotic bone10.1016/S0020-1383(16)47004-X ↗
6. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration10.1016/j.stem.2012.02.003 ↗
7. Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site10.1007/s12015-014-9573-5 ↗
8. Aged osteoporotic bone marrow stromal cells demonstrate defective recruitment, mechanosensitivity, and matrix deposition10.1159/000503444 ↗
9. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
10. Biomaterials that promote cell-cell interactions enhance the paracrine function of MSCs10.1016/j.biomaterials.2017.06.019 ↗
11. Hydrogel Culture Surface Stiffness Modulates Mesenchymal Stromal Cell Secretome and Alters Senescence10.1089/ten.tea.2020.0030 ↗
12. Rescuing mesenchymal stem cell regenerative properties on hydrogel substrates post serial expansion
13. Soft extracellular matrix enhances inflammatory activation of mesenchymal stromal cells to induce monocyte production and trafficking
14. Engineering principles for guiding spheroid function in the regeneration of bone, cartilage, and skin
15. Increased survival and function of mesenchymal stem cell spheroids entrapped in instructive alginate hydrogels10.5966/sctm.2015-0211 ↗
16. Porous bio-click microgel scaffolds control hMSC interactions and promote their secretory properties10.1016/j.biomaterials.2019.119725 ↗
17. Niche-mimicking interactions in peptide-functionalized 3D hydrogels amplify mesenchymal stromal cell paracrine effects
18. Charles River, Ovariectomy, Surgery Code: OVARIEX, (2017). https://www.criver.com/sites/default/files/resource-files/ovariectomy.pdf.
19. Ovariectomy differential influence on some hemostatic markers of mice and rats10.1538/expanim.14-0052 ↗
20. Supramolecular polymer gels with potential model-network structure10.1039/C3PY01692G ↗
21. Adaptable fast relaxing boronate-based hydrogels for probing cell–matrix interactions10.1002/advs.201800638 ↗
22. Clickable microgel scaffolds as platforms for 3D cell encapsulation10.1002/adhm.201700254 ↗
23. Mesenchymal stem cell perspective: cell biology to clinical progress10.1038/s41536-019-0083-6 ↗
24. NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation10.1073/pnas.1300532110 ↗
25. TIMP-1 inhibits proliferation and osteogenic differentiation of hBMSCs through Wnt/β-catenin signaling10.1042/BSR20181290 ↗
26. TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced osteoporosis10.1016/j.bone.2018.09.012 ↗
27. Mechanisms involved in enhancement of osteoclast formation by activin-A10.1002/jcb.26906 ↗
28. Inhibitory Effects of Activin-A on Osteoblast Differentiation During Cultures of Fetal Rat Calvarial Cells10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.0.CO;2-T ↗
29. TNF-α contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation10.1016/j.biopha.2018.03.080 ↗
30. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
31. Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women10.1359/jbmr.090802 ↗
32. Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells10.1186/s12929-019-0556-3 ↗
33. Monocyte chemoattractant protein-1 deficiency attenuates oxidative stress and protects against ovariectomy-induced chronic inflammation in mice10.1371/journal.pone.0072108 ↗
34. You talking to me? cadherin and integrin crosstalk in biomaterial design10.1002/adhm.202002048 ↗
35. Supplement: Nuclear mechanosensing controls MSC osteogenic potential through HDAC epigenetic remodeling10.1073/pnas.2006765117 ↗
36. Running against the Wnt: how Wnt/β-catenin suppresses adipogenesis
37. Convergence of Wnt, beta-catenin, and cadherin pathways10.1126/science.1094291 ↗
38. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/-catenin signaling, osteoblast function, and bone formation10.1128/MCB.00349-08 ↗
39. Crosstalk between wnt/β-Catenin and NF-κB Signaling Pathway during inflammation
40. N-cadherin adhesive interactions modulate matrixmechanosensing and fate commitment ofmesenchymal stem cells10.1038/nmat4725 ↗